Skip to main content
Chemical, Biological, Radiological and Nuclear Risk Mitigation
  • Project

PROJECT 085: LABPLUS AFRICA - Strengthening Laboratory Capacities in Africa against CoVID-19 and other epidemics: from set up in Senegal to scale up in Africa

Context

Large-scale epidemics are becoming more and more frequent and constitute a health, economic, social and security threat. Resource-limited, at-risk settings are most vulnerable to the burden and amplification of epidemics — particularly in Africa. This is notably true of CoVID-19, which rapidly spread to other Chinese provinces and to several countries, including in Africa. Hence, mitigating the risk of extension of the SARS-CoV-2 epidemics in Africa is of the utmost importance to preserve the continent as much as possible from the human and economic consequences associated with a possible large-scale spread of the virus.

This action proposes a strategic framework to reinforce preparedness and response to CoVID-19 in Africa as well as to implement an innovative approach to address unmet needs of diagnostics and health services through mobile platforms delivering laboratory and health services to detect, respond, control and prevent epidemics in Africa focusing on access driven business models, local capacities and sustainability.

Overall objective

The project’s overall objective is to address immediate needs for response and preparedness in Africa for the CoVID-19 and for other epidemic prone diseases (e.g. haemorrhagic fever) in affected and non-affected countries respectively.

Specific objectives

  1. To adopt a concerted approach of Africa CDC/WHO Afro/WHO/ECOWAS along with Institut Pasteur de Dakar (IPD) as a regional center designated by the 3 organizations;
  2. To build a more sustainable and affordable ecosystem to support health system with mobile platforms for diagnostics and health services provided by Praesens Care (PC).

Activities

  1. Establish IPD as the regional hub for first and referral diagnosis with cutting edge technologies in order to accelerate early detection, management and control of outbreak.
  2. Upgrade IPD campus’s facilities to welcome and train an increased number of African institution staff
  3. Develop a theoretical and hands-on workshop program for training in Surveillance and Epidemics Preparedness, Intelligence, Response and Control as well as on Mobile Lab use and deployment
  4. Launch the production of five new Mobile Labs and set up two African Regional Mobile Labs Hub

Achievements

  • IPD has improved its biological waste management and biobanking capacities
  • Next Generation Sequencing system and Maldi-Toff mass spectra have been delivered to IPD and regularly used
  • The new training Centre of Excellence located within IPD is under construction.
  • The IPD mobile lab was upgraded and deployed by trained teams for field mission in Senegal
  • A training program on genomic algebra is developed and a first training occurred mid-March 2023
  • The five new mobile labs are built and ready for shipment 
CBRN areas
  • Bio-safety/bio-security
  • Crisis management
  • First response
  • Post incident recovery
  • Safety and security
CBRN categories
  • Biological
CoE Region
  • AAF - African Atlantic Façade
  • ECA - Eastern and Central Africa
  • NAS - North Africa and Sahel
  • 14 JUNE 2023
Project 085 Factsheet

Stakeholders

Coordinators

European Commission

European Union External Action Service

United Nations Interregional Crime and Justice Research Institute

Participants

This project is part of a pre-existing EU activity in the regions and has not resulted from the submission of a CoE project proposal. Due to the different origin of the project, not all countries involved are CoE partner countries.

** This designation is without prejudice to positions on status, and is in line with UNSCR 1244/1999 and the ICJ Opinion on the Kosovo declaration of independence.

*** This designation shall not be construed as recognition of a State of Palestine and is without prejudice to the individual positions of the Member States on this issue.